Detalhe da pesquisa
1.
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.
Ann Rheum Dis
; 81(3): 335-343, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706874
2.
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis.
Ann Rheum Dis
; 79(10): 1290-1297, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32788396
3.
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.
Mod Rheumatol
; 30(1): 36-43, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784354
4.
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
Ann Rheum Dis
; 78(7): 890-898, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31040122
5.
Degradation of Azo Dye Solutions by a Nanocrystalline Fe-Based Alloy and the Adsorption of Their By-Products by Cork.
Materials (Basel)
; 16(24)2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38138753
6.
Pooled Analysis of Baricitinib Tolerability in Patients With Atopic Dermatitis in Relation to Acne, Headache, and Gastrointestinal Events From 8 Clinical Trials.
Dermatitis
; 34(4): 308-314, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749121
7.
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Adv Ther
; 40(4): 1867-1883, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802049
8.
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
J Dermatolog Treat
; 34(1): 2161812, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546346
9.
Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis.
RMD Open
; 9(3)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37604638
10.
Arabian Levantine viper bite induces thrombocytopenia - a case report.
J Med Life
; 15(6): 867-870, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35928351
11.
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Adv Ther
; 39(11): 4910-4960, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063279
12.
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
Am J Clin Dermatol
; 22(3): 395-405, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826132
13.
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate.
Arthritis Care Res (Hoboken)
; 72(8): 1112-1121, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31233281
14.
Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis.
Lancet Rheumatol
; 2(6): e347-e357, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273598
15.
Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib.
RMD Open
; 6(3)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028675
16.
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy.
Arthritis Res Ther
; 21(1): 102, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999933
17.
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis.
Arthritis Rheumatol
; 71(7): 1042-1055, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663869
18.
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Adv Ther
; 40(9): 4114-4115, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347406
19.
Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis.
Arthritis Rheumatol
; 70(12): 1923-1932, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30058112
20.
Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Curr Med Res Opin
; 22(4): 751-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16684436